{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T03:45:56Z","timestamp":1793245556594,"version":"4.5.0"},"reference-count":26,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T00:00:00Z","timestamp":1732752000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>Neurofibromatosis type 1 (NF1) is a rare autosomal dominant disorder that affects the skin, eyes and peripheral nervous system. It is rarely associated with glaucoma, especially in pediatric patients. We herein report an unusual case of corneal degeneration in a child with NF1, characterized by peripheral corneal leukoma and a membrane under Descemet\u2019s membrane. This finding offers new insights for the ophthalmic diagnosis of NF1.<\/jats:p>","DOI":"10.3389\/fonc.2024.1469969","type":"journal-article","created":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T06:34:18Z","timestamp":1732775658000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Secondary childhood glaucoma in neurofibromatosis type 1: an unusual corneal leukoma case report"],"prefix":"10.3389","volume":"14","author":[{"given":"Ling Ying","family":"Ge","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han Mu","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,11,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1055\/s-0036-1579766","article-title":"Neurofibromatosis: A review of NF1, NF2, and schwannomatosis","volume":"5","author":"Kresak","year":"2016","journal-title":"J Pediatr Genet"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaad.2008.12.051","article-title":"Neurofibromatosis type 1","volume":"61","author":"Boyd","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1097\/ICU.0000000000000609","article-title":"Neuro-ophthalmic manifestations of the phakomatoses","volume":"30","author":"Douglas","year":"2019","journal-title":"Curr Opin Ophthalmol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1111\/ceo.14039","article-title":"Approach to childhood glaucoma: A review","volume":"50","author":"Karaconji","year":"2022","journal-title":"Clin Exp Ophthalmol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2009.06.019","article-title":"Glaucoma and globe enlargement associated with neurofibromatosis type 1","volume":"116","author":"Morales","year":"2009","journal-title":"Ophthalmology"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1007\/s00347-023-01828-2","article-title":"Glaukom im S\u00e4uglings- und Kindesalter [Glaucoma in infancy and childhood","volume":"120","author":"Stingl","year":"2023","journal-title":"Ophthalmologie"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S102830","article-title":"Neurofibromatosis: an update of ophthalmic characteristics and applications of optical coherence tomography","volume":"10","author":"Abdolrahimzadeh","year":"2016","journal-title":"Clin Ophthalmol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(83)34371-2","article-title":"Ocular neurofibromatosis","volume":"90","author":"Brownstein","year":"1983","journal-title":"Ophthalmology"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.survophthal.2017.10.007","article-title":"Ophthalmic manifestations in neurofibromatosis type 1","volume":"63","author":"Kinori","year":"2018","journal-title":"Surv Ophthalmol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1002\/jnr.24241","article-title":"Pathophysiology and\u00a0management of glaucoma associated with phakomatoses","volume":"97","author":"Thavikulwat","year":"2018","journal-title":"J Neurosci Res"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.2006.045906","article-title":"Guidelines for the diagnosis and management of individuals with neurofibromatosis 1","volume":"44","author":"Ferner","year":"2007","journal-title":"J Med Genet"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2012.01.027","article-title":"Congenital ectropion uvea and mechanisms of glaucoma in neurofibromatosis type 1: new insights","volume":"119","author":"Edward","year":"2012","journal-title":"Ophthalmology"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1002\/ana.21107","article-title":"Optic pathway gliomas in neurofibromatosis-1: controversies and recommendations","volume":"61","author":"Listernick","year":"2007","journal-title":"Ann Neurol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.4103\/ijo.IJO_317_22","article-title":"Posterior corneal morphological changes in primary congenital glaucoma","volume":"70","author":"Gupta","year":"2022","journal-title":"Indian J Ophthalmol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jfo.2018.05.007","article-title":"Haab striae: Optical coherence tomographic analysis","volume":"42","author":"Benito-Pascual","year":"2019","journal-title":"J Fr Ophtalmol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.4103\/ijo.IJO_1967_20","article-title":"Corneal endothelial cells and central corneal thickness in patients with neurofibromatosis type 1","volume":"69","author":"Florou","year":"2021","journal-title":"Indian J Ophthalmol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-020-04717-5","article-title":"Ocular surface involvement in patients with neurofibromatosis type 1 syndrome","volume":"258","author":"Moramarco","year":"2020","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1167\/tvst.8.3.23","article-title":"Representation of central endothelial cell density by analysis of single best specular microscopy image regardless of cell size variance","volume":"8","author":"Shi","year":"2019","journal-title":"Transl Vis Sci Technol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199105023241812","article-title":"Neurofibromatosis: past, present, and future","volume":"324","author":"Riccardi","year":"1991","journal-title":"N Engl J Med"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(90)90252-A","article-title":"Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus","volume":"62","author":"Viskochil","year":"1990","journal-title":"Cell"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1038\/eye.2013.15","article-title":"Corneal endothelium: developmental strategies for regeneration","volume":"27","author":"Zavala","year":"2013","journal-title":"Eye (Lond)"},{"key":"B22","doi-asserted-by":"publisher","first-page":"475392","DOI":"10.1155\/2015\/475392","article-title":"SLC4A11 and the pathophysiology of congenital hereditary\u00a0endothelial dystrophy","volume":"2015","author":"Patel","year":"2015","journal-title":"BioMed Res Int"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M109.094680","article-title":"SLC4A11 prevents osmotic imbalance leading to corneal endothelial dystrophy, deafness, and polyuria","volume":"285","author":"Gr\u00f6ger","year":"2010","journal-title":"J Biol Chem"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.13-12089","article-title":"Mice with a targeted disruption of Slc4a11 model the progressive corneal changes of congenital hereditary endothelial dystrophy","volume":"54","author":"Han","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B25","article-title":"Healing of corneal epithelial defects in plasminogen- and fibrinogen-deficient mice","volume":"39","author":"Kao","year":"1998","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B26","first-page":"67","article-title":"Persistent corneal haze after excimer laser photokeratectomy in plasminogen-deficient mice","volume":"41","author":"Drew","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2024.1469969\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T06:34:20Z","timestamp":1732775660000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2024.1469969\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,28]]},"references-count":26,"alternative-id":["10.3389\/fonc.2024.1469969"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2024.1469969","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,28]]},"article-number":"1469969"}}